3bel: Difference between revisions
No edit summary |
No edit summary |
||
| Line 33: | Line 33: | ||
</div> | </div> | ||
<div class="pdbe-citations 3bel" style="background-color:#fffaf0;"></div> | <div class="pdbe-citations 3bel" style="background-color:#fffaf0;"></div> | ||
== References == | == References == | ||
<references/> | <references/> | ||
| Line 48: | Line 45: | ||
[[Category: Struble, G T]] | [[Category: Struble, G T]] | ||
[[Category: Xu, G]] | [[Category: Xu, G]] | ||
[[Category: Alternative splicing]] | |||
[[Category: Anti-oncogene]] | [[Category: Anti-oncogene]] | ||
[[Category: Atp-binding]] | [[Category: Atp-binding]] | ||
| Line 57: | Line 55: | ||
[[Category: Nucleotide-binding]] | [[Category: Nucleotide-binding]] | ||
[[Category: Phosphoprotein]] | [[Category: Phosphoprotein]] | ||
[[Category: Polymorphism]] | |||
[[Category: Receptor]] | [[Category: Receptor]] | ||
[[Category: Secreted]] | [[Category: Secreted]] | ||
| Line 62: | Line 61: | ||
[[Category: Transmembrane]] | [[Category: Transmembrane]] | ||
[[Category: Tyrosine-protein kinase]] | [[Category: Tyrosine-protein kinase]] | ||
[[Category: Ubl conjugation]] | |||